First Header Logo Second Header Logo

Connection

Caio Max Rocha Lima to Aniline Compounds

Back to Details
This is a "connection" page, showing publications Caio Max Rocha Lima has written about Aniline Compounds.
Caio Max Rocha Lima
Connection Strength
0.060
Aniline Compounds
  1. Cleary JM, Lima CM, Hurwitz HI, Montero AJ, Franklin C, Yang J, Graham A, Busman T, Mabry M, Holen K, Shapiro GI, Uronis H. A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors. Invest New Drugs. 2014 Oct; 32(5):937-45.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.